CMND
NASDAQ · Pharmaceuticals
Clearmind Medicine Inc
$0.69
+0.02 (+3.46%)
Financial Highlights (FY 2025)
Revenue
523.5K
Net Income
68.9K
Gross Margin
29.7%
Profit Margin
13.2%
Rev Growth
+19.2%
D/E Ratio
0.43
Revenue & Net Income
Margin Trends
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Gross Margin | 29.7% | 29.7% | 29.7% |
| Operating Margin | 17.0% | 14.9% | 15.8% |
| Profit Margin | 13.2% | 15.1% | 16.6% |
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 523.5K | 483.3K | 576.6K |
| Gross Profit | 155.5K | 143.5K | 171.2K |
| Operating Income | 88.8K | 72.1K | 91.4K |
| Net Income | 68.9K | 73.1K | 95.7K |
| Gross Margin | 29.7% | 29.7% | 29.7% |
| Operating Margin | 17.0% | 14.9% | 15.8% |
| Profit Margin | 13.2% | 15.1% | 16.6% |
| Rev Growth | +19.2% | +7.8% | +18.0% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 383.0K | 408.4K | 345.3K |
| Total Equity | 883.2K | 914.7K | 918.2K |
| D/E Ratio | 0.43 | 0.45 | 0.38 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 118.6K | 102.7K | 135.6K |
| Free Cash Flow | 93.6K | 59.2K | 119.0K |